# Efficacy and Safety of Tofacitinib in Patients With Prurigo Nodularis

> **NCT06201715** · NA · UNKNOWN · sponsor: **Second Affiliated Hospital, School of Medicine, Zhejiang University** · enrollment: 24 (estimated)

## Conditions studied

- Prurigo Nodularis
- Itch

## Interventions

- **DRUG:** Tofacitinib 5 MG

## Key facts

- **NCT ID:** NCT06201715
- **Lead sponsor:** Second Affiliated Hospital, School of Medicine, Zhejiang University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-05-01
- **Primary completion:** 2025-06-30
- **Final completion:** 2025-12-30
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2024-04-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06201715

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06201715, "Efficacy and Safety of Tofacitinib in Patients With Prurigo Nodularis". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT06201715. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*